Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality
Open Heart
.
2017 Sep 2;4(2):e000642.
doi: 10.1136/openhrt-2017-000642.
eCollection 2017.
Authors
James J DiNicolantonio
1
,
James H O'Keefe
1
,
Mark F McCarty
2
Affiliations
1
Preventive Cardiology, Saint Luke's Mid America Heart Institute, Kansas, USA.
2
Catalytic Longevity, Encinitas, California, USA.
PMID:
28912955
PMCID:
PMC5589004
DOI:
10.1136/openhrt-2017-000642
No abstract available
Keywords:
aspirin; cardiovascular; nutraceuticals.
Publication types
Editorial